Denali Therapeutics
DNLI
DNLI
199 hedge funds and large institutions have $2.84B invested in Denali Therapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 79 increasing their positions, 54 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $2.73B → $2.84B (+$109M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.44% less ownership
Funds ownership: 75.39% → 74.95% (-0.44%)
Holders
199
Holding in Top 10
3
Calls
$3.05M
Puts
$506K
Top Buyers
| 1 | +$19.4M | |
| 2 | +$13.6M | |
| 3 | +$9.44M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$8.54M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$8.08M |
Top Sellers
| 1 | -$46M | |
| 2 | -$34.7M | |
| 3 | -$15.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.8M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$10.7M |